Ondansetron
Product Images NDC 53002-0570

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 53002-0570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Actavislogo

FDA Label Image

Label Image (Lbl530020570)

Ondansetron HCl 4 mg tablets packaging label from RPK Pharmaceuticals, Inc., for a bottle containing 10 tablets. The label includes directions to take the specified number of tablets times a day as directed by a prescriber, along with dosing and clinic information sections, a barcode, and product identification details including the 53002-0570 NDC.*

FDA Label Image

Ondanfig1

Chemical structure of Ondansetron hydrochloride dihydrate, showing the molecular arrangement of atoms including a benzene ring, methyl groups, and a heterocyclic imidazole ring with associated hydrogen chloride and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.